UK pharma off-license

Off-patent, off-label medications could help thousands at very little cost. At the time of writing, the UK government is about to get a second reading of a piece of legislation that should it pass will allow doctors to prescribe off-patent generic pharmaceuticals for diseases, such as breast cancer, multiple sclerosis and Parkinson's disease, for which those drugs were not approved initially. Drugs that cost mere pennies once their patents expire do not turn sufficient profit for the original marketing company but can still be profitable for generic manufacturers.